Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 67.18M
47.81x6.38x-0.76x5.3x22.4x30.77x2.59% 320B
24.92x2.09x-18.65x3.41x12.14x19.85x1.58% 73.39B
11.8x12.49x0.07x5.99x9.22x10.13x - 9.42B
17.1x1.47x0.85x2.17x7.46x8.91x2.61% 8.56B
23.1x6.14x2.32x6.59x18.63x19.47x-.--% 4.4B
35.94x - 0.23x6.78x19.4x31.42x - 4.16B
38.92x2.32x-1.27x2.2x26.87x40.42x0.79% 3.39B
110.89x - -0.68x - - - -.--% 2.79B
17.04x0.75x-0.62x1.33x23.74x40.64x4.15% 1.05B
51.84x - -0.1x - - - - 1.03B
-7.38x12.32x0.45x202.27x-6.56x-5.09x-.--% 952M
Average 33.82x 5.50x -1.65x 26.23x 14.81x 21.84x 1.47% 35.77B
Weighted average by Cap. 42.27x 5.63x -3.73x 5.36x 19.94x 27.90x 2.35%
Specialty & Advanced Pharmaceuticals